Ledger.Open graph →

SEC Form D · Amendment · filed July 15, 2020

INVO Bioscience, Inc

Offering

$3.5M

Sold

$3.5M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SARASOTA, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael J. Campbell · Sarasota, FLExec · Director Trent Davis · Sarasota, FLDirector Kevin Doody · Sarasota, FLDirector Steven Shum · Sarasota, FLExec · Director Kathleen T. Karloff · Sarasota, FLDirector Debra T. Hoopes · Sarasota, FLExec Neil Asinger · New York, NYDirector Adrian Waters · Dublin 2, IrelandDirector Sandeep Soni · New York, NYDirector Harry Demott · New York, NYExec David E. Kass · Columbus, OHExec · Director David Andonian · New York, NYExec · Director Brett Paulk · Tomball, TXExec · Director Curtis Haines · Tomball, TXDirector Rob Ball · Grand Rapids, MIDirector R. S. Churchill · Grand Rapids, MIExec John Galdieri Iii · ANNAPOLIS, MDExec · Director Patrick Britton-Harr · ANNAPOLIS, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗